Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

IntroductionChemotherapy-induced peripheral neuropathy (CIPN) can greatly impair function, leading to disability or truncated treatment in cancer patients. Previous animal studies show that cannabidiol (CBD) and delta-9- tetrahydrocannabinol (THC) can ameliorate CIPN. This study assessed the effect...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Marisa Weiss, Muath Giaddui, Stephanie Kjelstrom, Joseph Gary, Sara Jane Ward, Jessica Burrell, Katherine Diguilio, Gabrielle Bidas, Ebuwa Erebor, Sam Meske, Lisa Saeed, Sarah Windawi, Katherine Aliano Ruiz, Arezoo Ghaneie, Julianne Hibbs, John Marks, David Holtz, Zonera Ali, Aarthi Shevade, Jennifer Sabol, Robin Ciocca, Eric Zeger, Paul Gilman, Sharon Larson, Shoichi Shimamoto, Diana Martinez
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-10-01
Edice:	Frontiers in Oncology
Témata:	chemotherapy-induced peripheral neuropathy cannabinoids cannabidiol (CBD) delta-9-tetrahydrocannabinol (THC) sensory impairment cancer
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1590168/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!